BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 31929855)

  • 1. Understanding of ROS-Inducing Strategy in Anticancer Therapy.
    Kim SJ; Kim HS; Seo YR
    Oxid Med Cell Longev; 2019; 2019():5381692. PubMed ID: 31929855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting antioxidants for cancer therapy.
    Glasauer A; Chandel NS
    Biochem Pharmacol; 2014 Nov; 92(1):90-101. PubMed ID: 25078786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Production of Reactive Oxygen Species as an Anticancer Strategy.
    Marioli-Sapsakou GK; Kourti M
    Anticancer Res; 2021 Dec; 41(12):5881-5902. PubMed ID: 34848443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.
    Smith DG; Magwere T; Burchill SA
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):229-49. PubMed ID: 21342042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular redox pathways as a therapeutic target in the treatment of cancer.
    Montero AJ; Jassem J
    Drugs; 2011 Jul; 71(11):1385-96. PubMed ID: 21812504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cell killing via ROS: to increase or decrease, that is the question.
    Wang J; Yi J
    Cancer Biol Ther; 2008 Dec; 7(12):1875-84. PubMed ID: 18981733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular chaperone Hsp90 as a target for oxidant-based anticancer therapies.
    Beck R; Dejeans N; Glorieux C; Pedrosa RC; Vásquez D; Valderrama JA; Calderon PB; Verrax J
    Curr Med Chem; 2011; 18(18):2816-25. PubMed ID: 21568884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into redox homeostasis as a therapeutic target in B-cell malignancies.
    Graczyk-Jarzynka A; Zagozdzon R; Muchowicz A; Siernicka M; Juszczynski P; Firczuk M
    Curr Opin Hematol; 2017 Jul; 24(4):393-401. PubMed ID: 28402987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
    Fang J; Seki T; Maeda H
    Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental therapeutics: targeting the redox Achilles heel of cancer.
    Cabello CM; Bair WB; Wondrak GT
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1022-37. PubMed ID: 18058573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids.
    Khan AQ; Rashid K; AlAmodi AA; Agha MV; Akhtar S; Hakeem I; Raza SS; Uddin S
    Biomed Pharmacother; 2021 Nov; 143():112142. PubMed ID: 34536761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy.
    Mani S; Swargiary G; Ralph SJ
    Mitochondrion; 2022 Jan; 62():50-73. PubMed ID: 34758363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The redox-active nanomaterial toolbox for cancer therapy.
    Ibañez IL; Notcovich C; Catalano PN; Bellino MG; Durán H
    Cancer Lett; 2015 Apr; 359(1):9-19. PubMed ID: 25597786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Polymeric Micelles for Combinational Oxidation Anticancer Therapy through Concurrent HO-1 Inhibition and ROS Generation.
    Noh J; Jung E; Lee J; Hyun H; Hong S; Lee D
    Biomacromolecules; 2019 Feb; 20(2):1109-1117. PubMed ID: 30605610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species in redox cancer therapy.
    Tong L; Chuang CC; Wu S; Zuo L
    Cancer Lett; 2015 Oct; 367(1):18-25. PubMed ID: 26187782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of oxidative stress as an anticancer strategy.
    Gorrini C; Harris IS; Mak TW
    Nat Rev Drug Discov; 2013 Dec; 12(12):931-47. PubMed ID: 24287781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species in cancer: Current findings and future directions.
    Nakamura H; Takada K
    Cancer Sci; 2021 Oct; 112(10):3945-3952. PubMed ID: 34286881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox Control in Acute Lymphoblastic Leukemia: From Physiology to Pathology and Therapeutic Opportunities.
    Chen Y; Li J; Zhao Z
    Cells; 2021 May; 10(5):. PubMed ID: 34067520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic Acid Coordinating with Sodium Selenite Promotes Paraptosis in Colorectal Cancer Cells by Disrupting the Redox Homeostasis and Activating the MAPK Pathway.
    Zhao S; Meng Y; Cai W; Luo Q; Gao H; Shen Q; Shi D
    Nutrients; 2024 Jun; 16(11):. PubMed ID: 38892670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prooxidant mechanism for the anticancer and chemopreventive properties of plant polyphenols.
    Khan HY; Zubair H; Ullah MF; Ahmad A; Hadi SM
    Curr Drug Targets; 2012 Dec; 13(14):1738-49. PubMed ID: 23140285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.